Development of AD214 a novel anti-fibrotic treatment for advanced Age related macular degeneration

  • Fletcher, Erica (Primary Chief Investigator (PCI))
  • Foley, Michael A (Chief Investigator (CI))
  • Guymer, Robyn Heather (Chief Investigator (CI))
  • Boyd, Benjamin (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/01/2131/12/23

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD687,994.00

Keywords

  • macular degeneration
  • chemokine receptor
  • Antibody therapy
  • pharmaceutical treatment
  • animal model